Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
about
Skeletal muscle dysfunction in chronic obstructive pulmonary diseaseCachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspectiveMuscle function in COPD: a complex interplayNutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysisRole of autophagy in COPD skeletal muscle dysfunctionOccupational Health Hazards among Sewage Workers: Oxidative Stress and Deranged Lung FunctionsReference values for vastus lateralis fiber size and type in healthy subjects over 40 years old: a systematic review and metaanalysisInflammation induced loss of skeletal muscleSatellite cells senescence in limb muscle of severe patients with COPDSix-minute walk distance in patients with severe end-stage COPD: association with survival after inpatient pulmonary rehabilitation2D-DIGE proteomic analysis of vastus lateralis from COPD patients with low and normal fat free mass index and healthy controlsQuantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional studyPredictors of mortality in elderly subjects with obstructive airway disease: the PILE scoreReduced HDAC2 in skeletal muscle of COPD patients.The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD.Skeletal muscle strength and endurance in recipients of lung transplants.Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditionsCortical implication in lower voluntary muscle force production in non-hypoxemic COPD patientsXanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Time course expression of Foxo transcription factors in skeletal muscle following corticosteroid administration.Respiratory muscle function and free radicals: from cell to COPD.A controlled study of community-based exercise training in patients with moderate COPDStructural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patientsImpact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease.Non-invasive ventilation (NIV) as an aid to rehabilitation in acute respiratory disease.Enhancing physical performance in chronic obstructive pulmonary diseaseObesity in chronic obstructive pulmonary disease: is fatter really better?Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms.American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation.Lung injury-dependent oxidative status and chymotrypsin-like activity of skeletal muscles in hamsters with experimental emphysemaThe prevalence of quadriceps weakness in COPD and the relationship with disease severity.Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD).Comparative assessment of the quadriceps and the diaphragm in patients with COPD.Reduced myotube diameter, atrophic signalling and elevated oxidative stress in cultured satellite cells from COPD patients.Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function.Chronic obstructive pulmonary disease. 5: systemic effects of COPDDevelopment of disability in chronic obstructive pulmonary disease: beyond lung function.Muscle strength, disability and mortality.Genome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls.
P2860
Q24792076-4B0A028B-D907-4AE5-985F-03E3886A47BFQ26749418-E7268A94-60FE-41F5-B2D7-A02C72EA7778Q26865732-96F5C236-0E72-4755-9F94-CF790B3AF8AAQ26995338-1B26BE82-477E-4852-AD23-5E701A41DC0DQ27015002-0BD7D720-94C2-4FF3-9644-DFB5C72C4EA2Q27026159-CAE9E9E8-7833-4685-83A0-1AA89737671BQ27027496-E8546182-7275-49CD-9084-114C7E1EF2E3Q28083759-BCB4D601-87AB-4F1B-8413-27C5A8D1BE90Q28728534-45B63621-9AB7-45F6-82C7-1246F0C8B44FQ30433001-C10275E0-BB86-497C-940D-AB41E35BA28AQ33634631-2764B1DE-2618-4E9E-87B8-81AC0487856EQ33640519-0AD02443-D049-40EB-A5DE-5B911BA7E335Q33683010-A078B0B0-9248-4343-86DA-A8831893E61FQ33708989-E49B0B23-8D37-468A-9DBD-6D6F5A536FB9Q33740032-B6EFFD36-AACD-483F-907E-F626CF59A70DQ33752238-6F313F62-3104-462F-9F57-663DBC6C2A71Q33804521-92454EA1-2CE5-494E-95DC-5EAAE4649A39Q33817452-1CE8AF31-8BA8-41B2-9BD5-DC8F914D563BQ33883806-1FBD8040-8646-41A1-B540-817F600FE1EFQ33901722-073BF59B-B5CD-475C-BB37-7196599FF0B9Q33910776-897C399C-BB6F-4F68-8D4F-DDA4740A942EQ33971084-3B45E797-D00F-4103-BA56-95CFEE792441Q34013355-39F3A731-969F-4B0B-A4FF-404B5EC05B79Q34061404-02C7E771-5987-4542-8E79-A0A4A87009DFQ34083585-2E7DB80B-633F-4855-84F8-42B8D6E50154Q34104149-6DB9D596-2A6D-47F7-9E84-4461762C685BQ34106173-489C3980-2C8C-443C-ABDC-8BC682FC8E0BQ34344150-DD01B4B9-D822-4535-9E80-A08C00BD6092Q34446644-7C759FE6-D187-4D6E-B307-EA91033457F1Q34535807-99F1E4AA-DFE1-4E16-9643-FA61D221317EQ34560066-B6D2CD3D-181D-4DA9-A195-FC6D46182484Q34575095-D5CF8A69-E192-405B-B191-FEC1988339BEQ34592328-45943834-DDCC-4381-A39B-4B85CD4598ADQ34606406-4D2763B7-75A0-4CAB-BB34-8857CE097A27Q34885462-5DE90929-3854-4B99-954E-26007463C388Q34903298-10E4B579-923C-4373-AA3C-4C694DF87E18Q35009945-E14BEE88-9CD0-4A78-BB41-F4D8B5006505Q35034806-4B31817D-07DA-437A-89F3-58D0017431B5Q35048452-BA1712DA-1AB5-437E-B2AD-4667AB5FA911Q35097330-E1B8D9CD-0CDB-48A0-BC05-E01603B6C726
P2860
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
@en
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
@nl
type
label
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
@en
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
@nl
prefLabel
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
@en
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
@nl
P2093
P2860
P1476
Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM.158.2.9711023
P407
P577
1998-08-01T00:00:00Z